Τόμος 2 (1988) – Τεύχος 2 – Άρθρο 2 – Επιθεώρηση Κλινικής Φαρμακολογίας και Φαρμακοκινητικής-Διεθνής Έκδοση – Volume 2 (1988) – Issue 2 – Article 2 – Epitheorese Klinikes Farmakologias και Farmakokinetikes-International Edition

Department of Biological Chemistry, University of Athens Medical School, Athens

pharmakonpress[at]pharmakonpress[.]gr

2.         Comings, D.E.: A general theory of carcinogenesis. Proc. Natl. Acad Sci. USA 70: 3324 (1973)

3.         Cavenee, W.K. et al.: Expression of recessive alleles by chromosomal mechanisms in retinoblastoma. Nature (London) 305: 779 (1983)

4.         Godbout, R., Dryja, T.P., Squire, J., Gallie, B.L., Phillips, R.A.: Somatic inactivation of genes on chromosome 13 is a common event in retinoblastoma. Nature (London) 304: 451 (1983)

5.         Benedict, W.F., Murphree, A.L., Banerjee, A., Spina, C.A., Sparkes, M.C., Sparkes, R.C.: Patient with chromosome deletion: Evidence that the retinoblastoma gene is a recessive cancer gene. Science 219: 973 (1983)

6.         Balaban, G„ Gilbert, F., Nichols, W., Meadows, A.T., Shields, J.: Abnormalities of chromosome No. 13 in retinoblasts from individuals with normal constitutional karyotypes. Cancer Genet. Cytogenetic 6: 213 (1982)

7.         Botstein, D., White, R.L., Skolnick, M., Davis, R.W.: Construction of a genetic linkage map in man using restriction fragment length polymorphisms. Am. J. Hum. Genet. 32: 314(1980)

8.         Cavenee, W.K., Leach, R.J., Mohandas, T., Pearson, P., White, R.L: Isolation and regional localization of DNA segments revealing polymorphic loci from human chromosome 13. Am. J. Hum. Genet. 36: 10 (1984)

9.         Dryja, T.P., Rapoport, J.M., Weichselbaum, R., Bruns, G.A.P.: Chromosome 13 restriction fragment length polymorphisms. Hum. Genet. 65: 320 (1984)

10.       Naylor, S.L., Sakaguchi, A.Y., Barker, D., White, R., Shows, T.B.: DNA polymorphic loci mapped to human chromosomes 3, 5, 9, 11, 17, 18 and 22. Proc. Natl. Acad. Sci. USA 81: 2447 (1984)

11.       Abramson, D.h., Ellsworth, R.M., Kithen, K.D., Tung, G.: Second non-ocular tumors in retinoblastoma survivors. Opthalmology 91: 1351 (1984)

12.       Hansen, M.J. et al.: Osteosarcoma and retinoblastoma: A shared chromosomal mechanism revealing recessive predisposition. Proc. Natl. Acad. Sci. USA 82: 6216(1985)

13.       Benedict, W.F., Banerjee, A., Mark, C., Murphree, A.L.: Nonrandom chromosomal changes in untreated retino-blastomas. Cancer Genet. Cytogenet. 10: 311 (1983)

14.       Kusnetsova, L.E., Prigogina, E.L, Pogosianz, H.E., Belkina, B.M.: Similar chromosomal abnormalities in several retinoblastomas. Hum. Genet. 61: 201 (1982)

15.       Potluri, V.R., Helson, L, Ellsworth, R.M. Reid, T., Gilbert, F.: Chromosomal abnormalities in human retinoblastoma. Cancer 58: 663 (1986)

16.       Squire, J., Phillips, R.A., Boyce, S., Godbout, R., Rogers, B„ Gallie, B.L.: Iso-chromosome 6p, a unique chromosomal abnormality in retinoblastoma: Verification by standard staining techniques, new densitometric methods, and somatic cell hybridization. Hum. Genet. 66: 46 (1984)

17.       Klein, G.: The role of gene dosage and genetic transposition in carcinogenesis. Nature (London) 294: 313 (1981)

18.       Gilbert, F. et al.: Abnormalities of chromosome 1p in human neuroblastoma tumors and cell lines. Cancer Genet. Cytogenet. 7: 33 (1982)

19.       Polturi, V.R., Gilbert, F.A.: Cytogenetic study of embryonal rhabdomyosarcoma. Cancer Genet. Cytogenet. 14: 169 (1985)

20.       Cruciger, V., Patha, K.S., Caillen, R.: Human breast carcinomas: Marker chromosomes involving 1q in seven cases. Cytogenet. Cell Genet. 17: 231 (1976)

21.       A.A, Sandberg: The chromosomes in human cancer and leukemia. Elsevier, New York, 1980

22.       Friend, S.H. et al.: A human DNA segment with properties of the gene that predisposes to retinoblastoma and osteosarcoma. Nature (London) 323: 643 (1986)

23.       Lee, W.H., Bookstein, R„ Hong, F„ Young, L.-S., Shew, J.-Y., Lee, E.Y.-H.P.: Human retinoblastoma susceptibility gene: cloning, identification and sequence. Science 235: 1394(1987)

24.       Fung, Y.-K. T„ Murphree, A.L., T’ang, A., Qian, J., Hinrichs, S.H., Benedict, W.F.: Structural evidence for the authenticity of the human retinoblastoma gene. Science 236: 1657 (1987)

25.       Lee, W.H.: The retinoblastoma susceptibility gene encodes a nuclear phosphoprotein associated with DNA binding activity. Nature (London) 329: 642 (1987)

26.       Ramsay, G., Stanton, L., Schwab, M., Bishop, J.M.: Human proto-oncogene N-myc encodes nuclear proteins that bind DNA. Molec. Cell. Biol. 6: 4450 (1986)

27.       Lengyel, P.: Biochemistry of interferons and their actions. Ann. Rev. Bioch. 51: 251 (1982)

28.       Gray, P.: Cloning and expression of cDNA for human lymphotoxin, a lymphokine with tumor necrosis activity. Nature (London) 312: 721 (1984)

29.       Cheifetz, S., Weatherbee, J.A., Isang, M.L., Anderson, J.K., Mole, J.E., Lucas, R., Masagui, J.: The transforming growth factor-beta system, a complex pattern of crossreactive ligands and receptors. Cell 48: 409 (1987)

30.       Resnitzky, D., Yarden, A., Zipori, D., Kimchi, A.: Autocrine beta-related interferon controls c-myc suppression and growth arrest during hematopoietic cell differentiation. Cell 46: 31 (1986)

31.       Knudson, A.G.: Hereditary cancer, oncogenes and antioncogenes. Cancer Res. 45: 1437 (1985)

32.       Kimchi, A., Wang, X.-F., Weinberg, R.A., Cheifetz, S., Massaqud, J.: Absence of TGF-β receptors and growth inhibitory responses in retinoblastoma cells. Science 240: 196 (1988)

33.       Wakefield, L.M., Smith, D.M., Masui, T., Harris, C.C., Sporn, M.B.: Distribution and modulation of the cellular receptor for transforming growth factor-beta. J. Cell Biol. 105: 965 (1987)

34.       Koufow, A., Hansen, M.F., Lampkrn, B.C., Workman, M.L., Copeland, N.G., Jenkins, N.A., Cavenee; W.K.: Loss of alleles at loci on human chromosome 11 during genesis of Wilms’ tumour. Nature (London) 309: 171 (1984)

35.       Orkin, S.H., Goldman, D.S., Sallon, S.E.: Development of homozygosity for chromosome 11 p markers in Wilms’ tumour. Nature (London) 309: 172 (1984)

36.       Reeve, A.E., Housiaux, P.J., Gardner, R.J.M., Chewings, W.E., Grindley, R.M., Millow, L.J.: Loss of a Harvey ras allele in sporadic Wilms’ tumour. Nature (London) 309: 174 (1984)

37.       Riccardi, V.M., Sujansky, E„ Smith, A.C., Francke, U.: Chromosomal imbalance in the aniridia-Wilms’ tumor association. Pediatrics 61: 604 (1978)

38.       Riccardi, V.M., Hittner, H., Francke, U., Junis, J., Ledbetter, D., Borges, W.: The Aniridia-Wilms s tumor association: the clinical role of chromosome band 11 p 13. Cancer Genet. Cytogenet. 2: 131 (1980)

39.       Brodeur, G.M., Green, A.A., Hayes, F.A., Williams, K.I., Williams, D.L., Tsiatis, A.A.: Cytogenetic features of human neuroblastomas and cell lines. Cancer Res. 41: 4678 (1981)

40.       Brodeur, G.M., Sekhon, G.S., Goldstein, M.N.: Chromosomal aberrations in human neuroblastomas. Cancer 40: 2256 (1 977)

41.       Knudson, A.G., Strong, L.C.: Mutation and cancer. Am. J. Hum. Genet. 24: 514 (1972)

pharmakonpress[at]pharmakonpress[.]gr

pharmakonpress[at]pharmakonpress[.]gr